← Leaderboards
Mitchell Allen Avery
University Of Mississippi
$9,035,799
Attributed
$9,035,799
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.2M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
CDC$8,468,972 · 2
NIH$566,827 · 1
By mechanism
U01$8,468,972 · 2
R01$566,827 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Mississippi
Same institution · by research overlap
- Alice M. Clark$4,666,208
- Mark T Hamann$5,667,987
- David Cole Stevens$1,908,090
- Sathyanarayana N Murthy$3,354,822
- Mahmoud A Elsohly$7,844,286
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionDrug Screening /EvaluationCandida AlbicansChemical Structure FunctionDiterpenesPneumocystis PneumoniaBiological ProductsPneumocystis CariniiAntifungal AgentsLeadOpportunistic InfectionsPeroxisomeCooperative StudyAntimalarial Agents
Grant awards (9)
Development and Testing of New Antimalarial Drugs$200,000
U01 · FY2009 · CI · contact PI
Development and Testing of New Antimalarial Drugs$1,055,172
U01 · FY2008 · CI · contact PI
Development and Testing of New Antimalarial Drugs$3,000,000
U01 · FY2007 · CI · contact PI
Development and Testing of New Antimalarial Drugs$2,713,800
U01 · FY2006 · CI · contact PI
Dev & Testing of New Medications for Treatment of Emerging Infectious Diseases$1,500,000
U01 · FY2006 · CI · contact PI
Development and Testing of New Antimalarial Drugs$0
U01 · FY2005 · CI
Development and Testing of New Antimalarial Drugs$0
U01 · FY2004 · CI
DEVELOPMENT OF NOVEL ANTIFUNGAL ANTIPC NATURAL PRODUCTS$287,602
R01 · FY2001 · AI
DEVELOPMENT OF NOVEL ANTIFUNGAL ANTIPC NATURAL PRODUCTS$279,225
R01 · FY2000 · AI